The Eighth edition of the Indian Pharmacopoeia (IP 2018) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health & Family Welfare, Government of India. The Indian Pharmacopoeia (IP) is published in fulfilment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules thereunder. It prescribes the standards for drugs produced and/or marketed in India and thus contributes to the control and assurance of the quality of the medicines. The standards of this pharmacopoeia are authoritative and legally enforceable. It intends to help in the licensing of manufacturing, inspection and distribution of medicines.
IP is published in continuing pursuit of the mission of IPC to improve the health of the people through ensuring the quality, safety and efficacy of medicines. The Commission has been receiving significant inputs from regulatory, industrial houses, academic institutions, national laboratories, individual scientists and others. Publication of IP at regular and shorter intervals is one of the main mandates of the Commission.
The Eighth edition of Indian Pharmacopoeia (IP 2018) is published in accordance with the principles and designed plan decided by the Scientific Body of the IPC. To establish transparency in setting standards for this edition, the contents of new monographs, revised appendices and other information have been publicized on the website of the IPC, besides following conventional approach of obtaining comments.
The feedback and inputs have been reviewed by the relevant Expert Committee to ensure the feasibility and practicability of the standards and methods revised. The principle of "openness, justice and fairness" is kept in mind during compiling and editing the contents of this edition.
This is the Eighth edition of the Indian Pharmacopoeia. It comprises of four volumes. Each volume has got different features.
Volume I: Notices; Preface; About Indian Pharmacopoeia Commission; Acknowledgements; Introduction; General Notices; General Chapters Reference Data and Index.
Volume II: General Notices; Dosage Forms (General Monographs); Drug Substances, Dosage Forms and Pharmaceutical Aids (A to M).
Volume III: General Notices; Drug Substances, Dosage Forms and Pharmaceutical Aids (N to Z); Vaccines and Immunosera for Human Use;
Herbs and Herbal Products; Blood and Blood-related Products; Biotechnology Derived Therapeutic Products, Allergen Products and Radiopharmaceutical Preparations.
Volume- IV : General Notices; Notices; Veterinary Products and Index.
.JPG)
0 Comments